Trial
NCT04108377
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
—
Condition
Asthma
Intervention
Roflumilast
Why stopped
Enrollment stopped secondary to completion of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-24